Patents by Inventor Jeroen VAN BERGENHENEGOUWEN

Jeroen VAN BERGENHENEGOUWEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nutritional composition for cancer
    Publication number: 20250017973
    Abstract: Provided herein is a nutritional composition having therapeutically effective amounts of a combination of (a) hydrolysed whey protein and (b) MCT for use in (i) reducing tumor growth and/or (ii) for use in improving treatment efficacy in a subject having cancer and undergoing cancer treatment.
    Type: Application
    Filed: September 12, 2024
    Publication date: January 16, 2025
    Applicant: N.V. Nutricia
    Inventors: Bram Jeroen van Bergenhenegouwen, Bram Dorresteijn, Hannah Rose Wardill
  • Composition with non-digestible oligosaccharides for attenuating nasal epithelial inflammation
    Patent number: 12023347
    Abstract: The present invention relates to the use of non-digestible oligosaccharides for the direct attenuation of nasal epithelial inflammation, in particular for non-allergic rhinitis, in particular for use in infants.
    Type: Grant
    Filed: February 1, 2022
    Date of Patent: July 2, 2024
    Inventors: Jeroen Van Bergenhenegouwen, Johan Garssen, Claudia Traidl-Hoffmann, Caroline Schlumprecht
  • COMPOSITION WITH NON-DIGESTIBLE OLIGOSACCHARIDES FOR ATTENUATING NASAL EPITHELIAL INFLAMMATION
    Publication number: 20220152066
    Abstract: The present invention relates to the use of non-digestible oligosaccharides for the direct attenuation of nasal epithelial inflammation, in particular for non-allergic rhinitis, in particular for use in infants.
    Type: Application
    Filed: February 1, 2022
    Publication date: May 19, 2022
    Inventors: Jeroen VAN BERGENHENEGOUWEN, Johan GARSSEN, Claudia TRAIDL-HOFFMANN, Caroline SCHLUMPRECHT
  • COMPOSITION WITH NON-DIGESTIBLE OLIGOSACCHARIDES FOR ATTENUATING NASAL EPITHELIAL INFLAMMATION
    Publication number: 20190388445
    Abstract: The present invention relates to the use of non-digestible oligosaccharides for the direct attenuation of nasal epithelial inflammation, in particular for non-allergic rhinitis, in particular for use in infants.
    Type: Application
    Filed: September 6, 2019
    Publication date: December 26, 2019
    Inventors: Jeroen VAN BERGENHENEGOUWEN, Johan GARSSEN, Claudia TRAIDL-HOFFMANN, Caroline SCHLUMPRECHT
  • Genes involved in immune related responses observed with asthma
    Publication number: 20040142891
    Abstract: Asthma is one of the most common chronic diseases (155 million people worldwide) and is rapidly increasing (20-50% per decade), particularly in children (currently 10% in The Netherlands). Asthma impairs the quality of life and is a major cause of absence from school and work. Asthma, if not treated properly, can be life threatening. The invention provides a nucleic acid library comprising genes or functional fragments thereof wherein the genes are essentially capable of initiation and/or progression and/or suppression and/or repression of an immune response.
    Type: Application
    Filed: October 2, 2003
    Publication date: July 22, 2004
    Applicant: Universiteit Utrecht
    Inventors: Pieter Cornelis Groot, Bram Jeroen van Bergenhenegouwen, Antonius Josephus Maria van Oosterhout
  • Genes involved in immune related responses observed with asthma
    Publication number: 20030232037
    Abstract: Asthma is one of the most common chronic diseases (155 million people worldwide) and is rapidly increasing (20-50% per decade), particularly in children (currently 10% in The Netherlands). Asthma impairs the quality of life and is a major cause of absence from school and work. Asthma, if not treated properly, can be life threatening. The invention provides a nucleic acid library comprising genes or functional fragments thereof wherein the genes are essentially capable of initiation and/or progression and/or suppression and/or repression of an immune response.
    Type: Application
    Filed: February 15, 2003
    Publication date: December 18, 2003
    Inventors: Pieter Cornelis Groot, Bram Jeroen van Bergenhenegouwen, Antonius Josephus Maria van Oosterhout